NBC Securities’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

NBC Securities’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,592	Closed	-$43	–	2547
2026 Q1	$43	Buy	+1,592	New	+$43	﹤0.01%	2525
2025 Q4	–	Sell	-1,592	Closed	-$31	–	2951
2025 Q3	$31	Buy	+1,592	New	+$31	﹤0.01%	2756

NBC Securities's VAXX Position: Q2 2026 in Review

NBC Securities sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2026, closing a stake of 1,592 shares — an estimated $43 sold.

NBC Securities first reported a position in VAXX in Q3 2025 and held it in 2 quarters. The position peaked at $43 in Q1 2026. 0 funds tracked by Wall St. Rank hold VAXX as of Q2 2026.

NBC Securities reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2026 after selling out during the quarter.
NBC Securities sold 1,592 Vaxxinity, Inc. Class A Common Stock shares in Q2 2026, an estimated $43.
NBC Securities first reported a position in Vaxxinity, Inc. Class A Common Stock in Q3 2025 and held it in 2 quarters.
NBC Securities's Vaxxinity, Inc. Class A Common Stock position peaked at $43 in Q1 2026.
0 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.